$SRCO Income Statement | Understand Stock

$SRCO

$0.08 +$0.00 (0.0%) Close

$SRCO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statement of Operations

In USD, except per-share amounts

	FY2026 12 months to Apr 30, 2026	FY2025 12 months to Apr 30, 2025	FY2024 12 months to Apr 30, 2024	FY2023 12 months to Apr 30, 2023	FY2022 12 months to Apr 30, 2022
Revenue
Information Technology
New World Health Brands
Wellness Products
Merchant Financing
Total Revenue
Less Cost of goods sold
Gross profit
Operating expenses:
Compensation and related costs
Accounting and legal Fees
Consulting fees
Rent and lease
Provision for credit losses
General office expenses
Research and development
Total operating expenses

Loss from operations
Other income (expense):
Commission on Municipal Bonds
Financing cost
Amortization of debt discount
Interest Expense on notes
Write off convertible notes
Liabilities written back
extinguishment of convertible debt
extinguishment of liabilities
Discount (Commitment Shares)
Warrant Expense
Loss (gain) in changes in fair value of derivative liability
Other income
Total other (income) expense

Net loss
Net profit (loss) attributable to minority shareholder
Net income (loss) attributed to common stockholders
Net loss attributed to common stockholders
Loss from continuing operations attributable to Sparta Commercial Services, Inc. common stockholders, basic
Loss from continuing operations attributable to Sparta Commercial Services, Inc. common stockholders, diluted
Net loss attributable to Sparta Commercial Services, Inc. common stockholders, basic
Net loss attributable to Sparta Commercial Services, Inc. common stockholders, diluted
Weighted average shares outstanding, basic
Weighted average shares outstanding, diluted

Comments